Injective Protocol (INJ) traded at $7.98 on November 9, 2026, retreating 2.62% over the prior 24 hours. The daily pullback trimmed but did not erase a strong recent run for the layer-1 blockchain token.
Over the past seven days, INJ advanced 11.30%, and the 30-day window showed a gain of 10.14%. Both figures place the asset in positive territory on a medium-term basis despite the single-session decline.
Injective Protocol carried a market capitalization of $0.82 billion at the time of pricing, keeping it within the mid-tier range of tracked crypto assets by that measure.
The combination of a modest daily dip alongside sustained weekly and monthly gains illustrates the volatility common to digital assets in this market-cap bracket. Whether the daily softness represents a brief pause or a broader shift in sentiment remained unclear from price data alone.
